The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volati ...

2025 is finally upon us and the trends for healthcare marketers continue to evolve.

Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, is more optimistic about the market after the correction. He believes ...

Short answer: most likely, yes. Clearly, navigating emerging markets will require a great deal of time and effort by pharma. These markets are highly dynamic, and the regional variations in ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. But with the proper planning and an agile approach, they can be more ...

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5%.